Market Cap

Dechra Pharmaceuticals plc Market Capitalization:

£4.39 Billion

GBP as of Jan. 1, 2024

US$5.59 Billion

business Dechra Pharmaceuticals plc Company Profile

Dechra Pharmaceuticals plc Main Stock Listing

LSE: DPH

Market Capitalization History of Dechra Pharmaceuticals plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Dechra Pharmaceuticals plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £4.39 B 50.32%
Jan. 1, 2023 £2.92 B -38.37%
Jan. 1, 2022 £4.74 B 15.20%
Jan. 1, 2021 £4.12 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Dechra Pharmaceuticals plc Categories

United Kingdom languages Healthcare languages Drug Manufacturers—General
United Kingdom Healthcare United Kingdom Drug Manufacturers—General

Stocks & Indices

Dechra Pharmaceuticals plc has the following listings and related stock indices.


Stock: LSE: DPH

Stock: FSX: 1PK

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.